Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.
about
Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@en
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@nl
type
label
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@en
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@nl
prefLabel
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@en
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Meta-analysis of efficacy and ...... ic non-small cell lung cancer.
@en
P2093
Li-Min Pang
Shu-Hua Zhang
P2860
P304
86816-86827
P356
10.18632/ONCOTARGET.19735
P407
P577
2017-07-31T00:00:00Z